Form 4 for IRWD IRONWOOD PHARMACEUTICALS INC
Accepted 2025-01-22 00:00:00 ET · period of report 2025-01-17 · accession 0000950170-25-007852 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-01-22 | 2025-01-17 | IRWD | Shetzline Michael | SVP, CMO, Head-Res, Drug | A - Grant | $0.00 | +48.2K | 461.9K | +12% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-01-17 | A | A | 48,224 | $0.00 | 461,943 | D | — | — |